ResearchMoz presents professional and in-depth study of "Big Data in the Healthcare & Pharmaceutical Industry: 2017 - 2030 - Opportunities, Challenges, Strategies & Forecasts".
“Big Data” originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyze. However, the scope of the term has significantly expanded over the years. Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyze large and variable collections of data, to solve complex problems.
Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=1293483
Amid the proliferation of real-time and historical data from sources such as connected devices, web, social media, sensors, log files and transactional applications, Big Data is rapidly gaining traction from a diverse range of vertical sectors. The healthcare and pharmaceutical industry is no exception to this trend, where Big Data has found a host of applications ranging from drug discovery and precision medicine to clinical decision support and population health management.
SNS Research estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4 Billion in 2017 alone. Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of more than 15% over the next three years.
The “Big Data in the Healthcare & Pharmaceutical Industry: 2017 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies. The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2017 through to 2030. The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 36 use cases, 6 regions and 35 countries.
The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.
The report covers the following topics:
Big Data ecosystem
Market drivers and barriers
Enabling technologies, standardization and regulatory initiatives
Big Data analytics and implementation models
Business case, application areas and use cases in the healthcare and pharmaceutical industry
34 case studies of Big Data investments by healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders
Future roadmap and value chain
Company profiles and strategies of over 240 Big Data vendors
Strategic recommendations for Big Data vendors, and healthcare and pharmaceutical industry stakeholders
Market analysis and forecasts from 2017 till 2030
Make an Enquiry about TOC @ http://www.researchmoz.us/enquiry.php?type=E&repid=1293483
Forecast Segmentation
Market forecasts are provided for each of the following submarkets and their subcategories:
Hardware, Software & Professional Services
Hardware
Software
Professional Services
Horizontal Submarkets
Storage & Compute Infrastructure
Networking Infrastructure
Hadoop & Infrastructure Software
SQL
NoSQL
Analytic Platforms & Applications
Cloud Platforms
Professional Services
Application Areas
Pharmaceutical & Medical Products
Core Healthcare Operations
Healthcare Support, Awareness & Disease Prevention
Health Insurance & Payer Services
Marketing, Sales & Other Applications
Use Cases
Drug Discovery, Design & Development
Medical Product Design & Development
Clinical Development & Trials
Precision Medicine & Genomics
Manufacturing & Supply Chain Management
Post-Market Surveillance & Pharmacovigilance
Medical Product Fault Monitoring
Clinical Decision Support
Care Coordination & Delivery Management
CER (Comparative Effectiveness Research) & Observational Evidence
Personalized Healthcare & Targeted Treatments
Data-Driven Preventive Care & Health Interventions
Surgical Practice & Complex Medical Procedures
Pathology, Medical Imaging & Other Medical Tests
Proactive & Remote Patient Monitoring
Predictive Maintenance of Medical Equipment
Pharmacy Services
Self-Care & Lifestyle Support
Medication Adherence & Management
Vaccine Development & Promotion
Population Health Management
Connected Health Communities & Medical Knowledge Dissemination
Epidemiology & Disease Surveillance
Health Policy Decision Making
Controlling Substance Abuse & Addiction
Increasing Awareness & Accessible Healthcare
Health Insurance Claims Processing & Management
Fraud & Abuse Prevention
Proactive Patient Engagement
Accountable & Value-Based Care
Data-Driven Health Insurance Premiums
Marketing & Sales
Administrative & Customer Services
Finance & Risk Management
Healthcare Data Monetization
Other Use Cases
Browse Report @ http://www.researchmoz.us/big-data-in-the-healthcare-pharmaceutical-industry-2017-2030-opportunities-challenges-strategies-forecasts-report.html
Regional Markets
Asia Pacific
Eastern Europe
Latin & Central America
Middle East & Africa
North America
Western Europe
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
“Big Data” originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyze. However, the scope of the term has significantly expanded over the years. Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyze large and variable collections of data, to solve complex problems.
Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=1293483
Amid the proliferation of real-time and historical data from sources such as connected devices, web, social media, sensors, log files and transactional applications, Big Data is rapidly gaining traction from a diverse range of vertical sectors. The healthcare and pharmaceutical industry is no exception to this trend, where Big Data has found a host of applications ranging from drug discovery and precision medicine to clinical decision support and population health management.
SNS Research estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4 Billion in 2017 alone. Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of more than 15% over the next three years.
The “Big Data in the Healthcare & Pharmaceutical Industry: 2017 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies. The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2017 through to 2030. The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 36 use cases, 6 regions and 35 countries.
The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.
The report covers the following topics:
Big Data ecosystem
Market drivers and barriers
Enabling technologies, standardization and regulatory initiatives
Big Data analytics and implementation models
Business case, application areas and use cases in the healthcare and pharmaceutical industry
34 case studies of Big Data investments by healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders
Future roadmap and value chain
Company profiles and strategies of over 240 Big Data vendors
Strategic recommendations for Big Data vendors, and healthcare and pharmaceutical industry stakeholders
Market analysis and forecasts from 2017 till 2030
Make an Enquiry about TOC @ http://www.researchmoz.us/enquiry.php?type=E&repid=1293483
Forecast Segmentation
Market forecasts are provided for each of the following submarkets and their subcategories:
Hardware, Software & Professional Services
Hardware
Software
Professional Services
Horizontal Submarkets
Storage & Compute Infrastructure
Networking Infrastructure
Hadoop & Infrastructure Software
SQL
NoSQL
Analytic Platforms & Applications
Cloud Platforms
Professional Services
Application Areas
Pharmaceutical & Medical Products
Core Healthcare Operations
Healthcare Support, Awareness & Disease Prevention
Health Insurance & Payer Services
Marketing, Sales & Other Applications
Use Cases
Drug Discovery, Design & Development
Medical Product Design & Development
Clinical Development & Trials
Precision Medicine & Genomics
Manufacturing & Supply Chain Management
Post-Market Surveillance & Pharmacovigilance
Medical Product Fault Monitoring
Clinical Decision Support
Care Coordination & Delivery Management
CER (Comparative Effectiveness Research) & Observational Evidence
Personalized Healthcare & Targeted Treatments
Data-Driven Preventive Care & Health Interventions
Surgical Practice & Complex Medical Procedures
Pathology, Medical Imaging & Other Medical Tests
Proactive & Remote Patient Monitoring
Predictive Maintenance of Medical Equipment
Pharmacy Services
Self-Care & Lifestyle Support
Medication Adherence & Management
Vaccine Development & Promotion
Population Health Management
Connected Health Communities & Medical Knowledge Dissemination
Epidemiology & Disease Surveillance
Health Policy Decision Making
Controlling Substance Abuse & Addiction
Increasing Awareness & Accessible Healthcare
Health Insurance Claims Processing & Management
Fraud & Abuse Prevention
Proactive Patient Engagement
Accountable & Value-Based Care
Data-Driven Health Insurance Premiums
Marketing & Sales
Administrative & Customer Services
Finance & Risk Management
Healthcare Data Monetization
Other Use Cases
Browse Report @ http://www.researchmoz.us/big-data-in-the-healthcare-pharmaceutical-industry-2017-2030-opportunities-challenges-strategies-forecasts-report.html
Regional Markets
Asia Pacific
Eastern Europe
Latin & Central America
Middle East & Africa
North America
Western Europe
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
No comments:
Post a Comment